Works matching DE "VALGANCICLOVIR"
Results: 292
Monitoring human cytomegalovirus infection in pediatric hematopoietic stem cell transplant recipients: using an affordable in-house qPCR assay for management of HCMV infection under limited resources.
- Published in:
- Transplant International, 2015, v. 28, n. 5, p. 594, doi. 10.1111/tri.12545
- By:
- Publication type:
- Article
(Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation.
- Published in:
- Transplant International, 2012, v. 25, n. 7, p. 723, doi. 10.1111/j.1432-2277.2012.01485.x
- By:
- Publication type:
- Article
Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients.
- Published in:
- Transplant International, 2011, v. 24, n. 9, p. 920, doi. 10.1111/j.1432-2277.2011.01285.x
- By:
- Publication type:
- Article
Pre-emptive intravenous ganciclovir versus valganciclovir prophylaxis for de novo cytomegalovirus-seropositive kidney-transplant recipients.
- Published in:
- Transplant International, 2010, v. 23, n. 10, p. 1056, doi. 10.1111/j.1432-2277.2010.01101.x
- By:
- Publication type:
- Article
Six months anti-viral prophylaxis significantly decreased cytomegalovirus disease compared with no anti-viral prophylaxis following renal transplantation.
- Published in:
- Transplant International, 2010, v. 23, n. 9, p. 897, doi. 10.1111/j.1432-2277.2010.01073.x
- By:
- Publication type:
- Article
A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection.
- Published in:
- Transplant International, 2010, v. 23, n. 5, p. 506, doi. 10.1111/j.1432-2277.2009.01017.x
- By:
- Publication type:
- Article
Limited sampling strategy for the estimation of the area under the concentration-time curve for ganciclovir in Chinese adult renal allograft recipients.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 5, p. 677, doi. 10.1007/s00228-018-02613-w
- By:
- Publication type:
- Article
Valganciclovir—Ganciclovir Use and Systematic Therapeutic Drug Monitoring. An Invitation to Antiviral Stewardship.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 1, p. 77, doi. 10.3390/antibiotics10010077
- By:
- Publication type:
- Article
Meet in the middle: Could cell mediated‐immunity assays be the answer for ideal Cytomegalovirus prophylaxis after lung transplantation? Observational study from a single center with intermittent antiviral prophylaxis.
- Published in:
- Transplant Infectious Disease, 2024, v. 26, n. 5, p. 1, doi. 10.1111/tid.14198
- By:
- Publication type:
- Article
Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients.
- Published in:
- Transplant Infectious Disease, 2024, v. 26, n. 3, p. 1, doi. 10.1111/tid.14279
- By:
- Publication type:
- Article
Trough ganciclovir concentration as predictor of leukopenia in lung transplant recipients receiving valganciclovir prophylaxis.
- Published in:
- Transplant Infectious Disease, 2023, v. 25, n. 6, p. 1, doi. 10.1111/tid.14141
- By:
- Publication type:
- Article
Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center.
- Published in:
- Transplant Infectious Disease, 2022, v. 24, n. 4, p. 1, doi. 10.1111/tid.13867
- By:
- Publication type:
- Article
Pharmacokinetics of valganciclovir and voriconazole during prolonged intermittent renal replacement therapy in a lung transplant recipient.
- Published in:
- Transplant Infectious Disease, 2022, v. 24, n. 2, p. 1, doi. 10.1111/tid.13818
- By:
- Publication type:
- Article
Novel risk factor for valganciclovir toxicity—NUDT15 genetic variant.
- Published in:
- Transplant Infectious Disease, 2022, v. 24, n. 2, p. 1, doi. 10.1111/tid.13799
- By:
- Publication type:
- Article
Letermovir conversion after valganciclovir treatment in cytomegalovirus high‐risk abdominal solid organ transplant recipients may promote development of cytomegalovirus‐specific cell mediated immunity.
- Published in:
- Transplant Infectious Disease, 2022, v. 24, n. 1, p. 1, doi. 10.1111/tid.13766
- By:
- Publication type:
- Article
Comparison of standard versus low‐dose valganciclovir regimens for cytomegalovirus prophylaxis in high‐risk liver transplant recipients.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 5, p. 1, doi. 10.1111/tid.13713
- By:
- Publication type:
- Article
The addition of adjunctive letermovir to valganciclovir for refractory cytomegalovirus viremia in kidney transplant recipients.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 4, p. 1, doi. 10.1111/tid.13693
- By:
- Publication type:
- Article
Conversion from cytomegalovirus universal prophylaxis with valganciclovir to the preemptive monitoring approach to manage leukopenia after kidney or pancreas transplantation.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 4, p. 1, doi. 10.1111/tid.13617
- By:
- Publication type:
- Article
CMV infection, valganciclovir exposure, and the risk of BK viremia and associated nephropathy after kidney transplantation: Is there a link?
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 4, p. 1, doi. 10.1111/tid.13597
- By:
- Publication type:
- Article
Examining valganciclovir prophylaxis duration among high‐risk donor seropositive/recipient seronegative heart transplant recipients in a larger cohort.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 4, p. 1, doi. 10.1111/tid.13581
- By:
- Publication type:
- Article
The burden of cytomegalovirus infection remains high in high‐risk kidney transplant recipients despite six‐month valganciclovir prophylaxis.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 4, p. 1, doi. 10.1111/tid.13577
- By:
- Publication type:
- Article
Trichodysplasia spinulosa: Case reports and review of literature.
- Published in:
- Transplant Infectious Disease, 2020, v. 22, n. 5, p. 1, doi. 10.1111/tid.13342
- By:
- Publication type:
- Article
Evaluation of a change in cytomegalovirus prevention strategy following pediatric solid organ transplantation.
- Published in:
- Transplant Infectious Disease, 2020, v. 22, n. 2, p. 1, doi. 10.1111/tid.13232
- By:
- Publication type:
- Article
Cytomegalovirus prophylaxis in seropositive renal transplant recipients receiving thymoglobulin induction therapy: Outcome and risk factors for late CMV disease.
- Published in:
- Transplant Infectious Disease, 2018, v. 20, n. 5, p. N.PAG, doi. 10.1111/tid.12929
- By:
- Publication type:
- Article
Cytomegalovirus infection in heart transplantation: A single center experience.
- Published in:
- Transplant Infectious Disease, 2018, v. 20, n. 4, p. 1, doi. 10.1111/tid.12896
- By:
- Publication type:
- Article
Low‐dose valganciclovir prohylaxis is efficacious and safe in cytomegalovirus seropositive heart transplant recipients with anti‐thymocyte globulin.
- Published in:
- Transplant Infectious Disease, 2018, v. 20, n. 3, p. 1, doi. 10.1111/tid.12868
- By:
- Publication type:
- Article
Impact of electronic health record‐based, pharmacist‐driven valganciclovir dose optimization in solid organ transplant recipients.
- Published in:
- Transplant Infectious Disease, 2018, v. 20, n. 2, p. 1, doi. 10.1111/tid.12849
- By:
- Publication type:
- Article
Safety and efficacy of foscarnet for the management of ganciclovir‐resistant or refractory cytomegalovirus infections: A single‐center study.
- Published in:
- Transplant Infectious Disease, 2018, v. 20, n. 2, p. 1, doi. 10.1111/tid.12852
- By:
- Publication type:
- Article
Low-dose valganciclovir prophylaxis for cytomegalovirus in intermediate-risk (R+) renal transplant recipients: Single-center experience.
- Published in:
- Transplant Infectious Disease, 2017, v. 19, n. 6, p. n/a, doi. 10.1111/tid.12780
- By:
- Publication type:
- Article
Valganciclovir ( VGCV) followed by cytomegalovirus ( CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study.
- Published in:
- Transplant Infectious Disease, 2017, v. 19, n. 6, p. n/a, doi. 10.1111/tid.12779
- By:
- Publication type:
- Article
Leflunomide for the treatment of trichodysplasia spinulosa in a liver transplant recipient.
- Published in:
- Transplant Infectious Disease, 2017, v. 19, n. 4, p. n/a, doi. 10.1111/tid.12702
- By:
- Publication type:
- Article
Fulminant Cytomegalovirus Myocarditis in an Immunocompetent Host: Resolution with Oral Valganciclovir.
- Published in:
- Texas Heart Institute Journal, 2014, v. 41, n. 5, p. 523, doi. 10.14503/THIJ-13-3504
- By:
- Publication type:
- Article
Oral valganciclovir versus intravenous ganciclovir as preemptive treatment for cytomegalovirus infection after living donor liver transplantation: A randomized trial.
- Published in:
- BioScience Trends, 2011, v. 5, n. 5, p. 217, doi. 10.5582/bst.2011.v5.5.217
- By:
- Publication type:
- Article
Optimizing ganciclovir and valganciclovir dosing regimens in pediatric patients with cytomegalovirus infection: a spotlight on therapeutic drug monitoring.
- Published in:
- Expert Review of Clinical Pharmacology, 2023, v. 16, n. 8, p. 727, doi. 10.1080/17512433.2023.2181161
- By:
- Publication type:
- Article
Congenital and Postnatal Cytomegalovirus: Case Series and State of the Science for Neonatal Providers.
- Published in:
- Neonatal Network, 2024, v. 43, n. 2, p. 92, doi. 10.1891/NN-2023-0069
- By:
- Publication type:
- Article
Congenital Cytomegalovirus—History, Current Practice, and Future Opportunities.
- Published in:
- Neonatal Network, 2020, v. 39, n. 5, p. 293, doi. 10.1891/0730-0832.39.5.293
- By:
- Publication type:
- Article
Efficacy of Valganciclovir Treatment Depends on the Severity of Hearing Dysfunction in Symptomatic Infants with Congenital Cytomegalovirus Infection.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 6, p. 1388, doi. 10.3390/ijms20061388
- By:
- Publication type:
- Article
Emerging (val)ganciclovir resistance during treatment of congenital CMV infection: a case report and review of the literature.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A comparative study of valaciclovir, valganciclovir, and artesunate efficacy in reactivated HHV‐6 and HHV‐7 infections associated with chronic fatigue syndrome/myalgic encephalomyelitis.
- Published in:
- Microbiology & Immunology, 2022, v. 66, n. 4, p. 193, doi. 10.1111/1348-0421.12966
- Publication type:
- Article
Successful Treatment with Oral Valganciclovir of Primary CMV Enterocolitis in a Congenitally Infected Infant.
- Published in:
- Fetal & Pediatric Pathology, 2011, v. 30, n. 6, p. 437, doi. 10.3109/15513815.2011.587501
- By:
- Publication type:
- Article
Cytomegalovirus infection of a cutaneous ulcer in a patient with ANCA-positive vasculitis.
- Published in:
- 2007
- By:
- Publication type:
- Report
Severe Diffuse Ulcerative Esophagitis Caused by Epstein-Barr Virus/Cytomegalovirus Coinfection in an Immunocompetent Individual.
- Published in:
- ACG Case Reports Journal, 2025, v. 12, n. 1, p. 1, doi. 10.14309/crj.0000000000001578
- By:
- Publication type:
- Article
Challenges in Managing Cytomegalovirus Colitis in a Complex Case of Ulcerative Colitis With Hyposplenism and Ustekinumab Therapy.
- Published in:
- ACG Case Reports Journal, 2024, v. 11, n. 10, p. 1, doi. 10.14309/crj.0000000000001536
- By:
- Publication type:
- Article
The Unmasking of Cytomegalovirus as an Accomplice to Helicobacter pylori-Induced Severe Acute Gastroenteritis in a Healthy Host.
- Published in:
- ACG Case Reports Journal, 2023, v. 10, n. 10, p. 1, doi. 10.14309/crj.0000000000001181
- By:
- Publication type:
- Article
Cytomegalovirus infection - cause of sensorineural deafness.
- Published in:
- 2016
- By:
- Publication type:
- Abstract
Valganciclovir and Risk for Neutropenia: When the Friend Becomes the Foe.
- Published in:
- Pediatric Transplantation, 2024, v. 28, n. 5, p. 1, doi. 10.1111/petr.14817
- By:
- Publication type:
- Article
Comment on "Evaluation of valganciclovir's neutropenia risk in pediatric solid organ transplant recipients utilizing two dosing regimens".
- Published in:
- Pediatric Transplantation, 2024, v. 28, n. 3, p. 1, doi. 10.1111/petr.14754
- By:
- Publication type:
- Article
Evaluation of valganciclovir's neutropenia risk in pediatric solid organ transplant recipients utilizing two dosing regimens.
- Published in:
- Pediatric Transplantation, 2024, v. 28, n. 2, p. 1, doi. 10.1111/petr.14714
- By:
- Publication type:
- Article
"Weight‐ing" for an answer on optimal valganciclovir prophylaxis dosing in pediatric solid organ transplantation recipients.
- Published in:
- Pediatric Transplantation, 2023, v. 27, n. 4, p. 1, doi. 10.1111/petr.14494
- By:
- Publication type:
- Article
Incidence of cytomegalovirus DNAemia in pediatric kidney, liver, and heart transplant recipients: Efficacy and risk factors associated with failure of weight‐based dosed valganciclovir prophylaxis.
- Published in:
- Pediatric Transplantation, 2023, v. 27, n. 4, p. 1, doi. 10.1111/petr.14493
- By:
- Publication type:
- Article